David Balli

David Balli is a computational biologist currently serving as the Director of Clinical Biomarkers at Bayer, where they lead efforts in advancing immunotherapies. With over 10 years of project leadership experience in immuno-oncology and cancer biology, David has a proven ability to translate complex data into testable hypotheses. Prior to Bayer, they held various leadership positions at Bristol Myers Squibb, including Associate Director, where they managed a team of computational biologists and oversaw analysis for late-stage oncology programs. David's academic background includes a B.A. in Biology with a minor in Biochemistry from DePauw University and a Ph.D. in Molecular and Developmental Biology from the University of Cincinnati.